SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate’s Dual Mechanism of Action Read More » December 9, 2024
Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision
Blueprint Medicines’ Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis
